Financials

News Ideas Minds Technicals

6814 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to LUKAS BIOMEDICAL INC operating, investing, and financing activities

6814 free cash flow for H2 23 is -9.59 M TWD. For 2023, 6814 free cash flow was -14.41 M TWD and operating cash flow was -11.75 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—